Prognosis assessment of CD44+/CD24− in breast cancer patients: a systematic review and meta-analysis

被引：0
|
作者：
Jingjing Gu
Dandan Chen
Zhiqiang Li
Yongliang Yang
Zhaoming Ma
Guanhong Huang
机构：
[1] Lianyungang Second People’s Hospital Affiliated to Bengbu Medical College,
来源：
Archives of Gynecology and Obstetrics | 2022年 / 306卷
关键词：
CD44; /CD24; Breast cancer; Meta-analysis; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1147 / 1160
页数：13
相关论文
共 50 条
  • [1] Prognosis assessment of CD44+/CD24- in breast cancer patients: a systematic review and meta-analysis
    Gu, Jingjing
    Chen, Dandan
    Li, Zhiqiang
    Yang, Yongliang
    Ma, Zhaoming
    Huang, Guanhong
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (04) : 1147 - 1160
  • [2] Prognostic significance of CD24 and CD44 in breast cancer: a meta-analysis
    Wang, Zhu
    Wang, Qianqian
    Wang, Qi
    Wang, Yanping
    Chen, Jie
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2017, 32 (01): : E75 - E82
  • [3] The CD44+/CD24− phenotype relates to ‘triple-negative’ state and unfavorable prognosis in breast cancer patients
    Alexandra Giatromanolaki
    Efthimios Sivridis
    Aliki Fiska
    Michael I. Koukourakis
    Medical Oncology, 2011, 28 : 745 - 752
  • [4] Expression of CD44+/CD24- Cells in Breast Cancer
    Lu, X. Q.
    Suo, Z. H.
    Ma, C. L.
    Xu, K. J.
    Liu, Y. S.
    Li, H. X.
    LABORATORY INVESTIGATION, 2009, 89 : 55A - 55A
  • [5] Expression of CD44+/CD24- Cells in Breast Cancer
    Lu, X. Q.
    Suo, Z. H.
    Ma, C. L.
    Xu, K. J.
    Liu, Y. S.
    Li, H. X.
    MODERN PATHOLOGY, 2009, 22 : 55A - 55A
  • [6] The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24- phenotype
    Zhao, Haishan
    Tang, Hongtao
    Xiao, Qinghuan
    He, Miao
    Zhao, Lin
    Fu, Yingzi
    Wu, Huizhe
    Yu, Zhaojin
    Jiang, Qian
    Yan, Yuanyuan
    Jin, Feng
    Wei, Minjie
    MOLECULAR MEDICINE REPORTS, 2016, 14 (06) : 5261 - 5270
  • [7] Clinicopathological analysis of CD44 and CD24 expression in invasive breast cancer
    Jang, Min Hye
    Kang, Hyun Jong
    Jang, Ki Seok
    Paik, Seung Sam
    Kim, Wan Seop
    ONCOLOGY LETTERS, 2016, 12 (04) : 2728 - 2733
  • [8] PREDICTIVE VALUE OF CD24 AND CD44 FOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND PROGNOSIS IN PATIENTS WITH PRIMARY BREAST CANCER
    Horiguchi, K.
    Toi, M.
    Horiguchi, S.
    Sugimoto, M.
    Naito, Y.
    Hayashi, Y.
    Ueno, T.
    Ohno, S.
    Sekine, S.
    Kitagawa, D.
    Aruga, T.
    Suzuki, E.
    Yamashita, T.
    Funata, N.
    Tomita, M.
    Eishi, Y.
    Kuroi, K.
    EJC SUPPLEMENTS, 2011, 9 (01): : 4 - 4
  • [9] Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis
    Liu, Gao
    Liu, Guo-Xing
    Fang, Yu
    Cao, Zhen-Yu
    Du, Hui-Hui
    Fu, Jie
    Qian, Ke
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2017, 32 (02): : E182 - E189
  • [10] CD44+/CD24- phenotype predicts a poor prognosis in triple-negative breast cancer
    Wang, Hui
    Wang, Li
    Song, Ying
    Wang, Shuhuai
    Huang, Xu
    Xuan, Qijia
    Kang, Xinmei
    Zhang, Qingyuan
    ONCOLOGY LETTERS, 2017, 14 (05) : 5890 - 5898
12345